×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LRMR – larimar therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LRMR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/4
04:05 pm
lrmr
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
Medium
Report
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
3/4
08:57 am
lrmr
Larimar Therapeutics price target raised to $12 from $11 at Wedbush [Yahoo! Finance]
Low
Report
Larimar Therapeutics price target raised to $12 from $11 at Wedbush [Yahoo! Finance]
3/3
10:18 am
lrmr
Larimar Therapeutics (LRMR) had its price target raised by Wedbush from $11.00 to $12.00. They now have an "outperform" rating on the stock.
Low
Report
Larimar Therapeutics (LRMR) had its price target raised by Wedbush from $11.00 to $12.00. They now have an "outperform" rating on the stock.
2/28
11:22 am
lrmr
Larimar Therapeutics (LRMR) Is Up 78.8% After Breakthrough Nod And $100M Raise Has The Bull Case Changed? [Yahoo! Finance]
Low
Report
Larimar Therapeutics (LRMR) Is Up 78.8% After Breakthrough Nod And $100M Raise Has The Bull Case Changed? [Yahoo! Finance]
2/25
08:59 pm
lrmr
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
Medium
Report
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
2/25
04:01 pm
lrmr
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
Low
Report
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
2/25
02:34 pm
lrmr
Larimar Therapeutics (LRMR) had its price target raised by Citigroup Inc. from $12.00 to $14.00. They now have a "buy" rating on the stock.
Medium
Report
Larimar Therapeutics (LRMR) had its price target raised by Citigroup Inc. from $12.00 to $14.00. They now have a "buy" rating on the stock.
2/25
08:22 am
lrmr
Larimar Therapeutics (LRMR) had its "outperform" rating reaffirmed by Wedbush. They now have a $11.00 price target on the stock.
High
Report
Larimar Therapeutics (LRMR) had its "outperform" rating reaffirmed by Wedbush. They now have a $11.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/5/2025
07:00 am
lrmr
larimar therapeutics, inc.
MISS
Report
-8.0%
larimar therapeutics, inc.
8/14/2025
07:00 am
lrmr
larimar therapeutics, inc.
BEAT
Report
14.5%
larimar therapeutics, inc.
3/24/2025
07:00 am
lrmr
larimar therapeutics, inc.
MISS
Report
-13.0%
larimar therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/2
07:47 pm
lrmr
Form SCHEDULE 13D/A Larimar Therapeutics, Filed by: Flynn James E
Low
Report
Form SCHEDULE 13D/A Larimar Therapeutics, Filed by: Flynn James E
3/2
07:46 pm
lrmr
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: Deerfield Mgmt HIF, L.P.
Low
Report
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: Deerfield Mgmt HIF, L.P.
3/2
04:31 pm
lrmr
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: THOMAS FRANK E
Low
Report
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: THOMAS FRANK E
3/2
04:31 pm
lrmr
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: Hamilton Thomas Edward
Low
Report
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: Hamilton Thomas Edward
3/2
04:31 pm
lrmr
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: SHERMAN JEFFREY W
Low
Report
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: SHERMAN JEFFREY W
2/27
06:03 am
lrmr
Form 8-K Larimar Therapeutics, For: Feb 25
Medium
Report
Form 8-K Larimar Therapeutics, For: Feb 25
2/26
04:25 pm
lrmr
Form 424B5 Larimar Therapeutics,
Medium
Report
Form 424B5 Larimar Therapeutics,
2/25
04:05 pm
lrmr
Form 424B5 Larimar Therapeutics,
Low
Report
Form 424B5 Larimar Therapeutics,
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: